收藏切换
Clinical observation of Linggui Zhugan decoction combined with sacubitril valsartan in the treatment of chronic heart failure
收藏切换
Qiang LU1, Yuelong NAN1, Xiaoping GUO1, *, Xiaoliang ZHANG2, Donghui SUN3, Wenzhong HAN1
World Clinical Drug | 2024, 45(11) : 1155 - 1160
Less
收藏切换
World Clinical Drug | 2024, 45(11): 1155-1160
• Article •
Clinical observation of Linggui Zhugan decoction combined with sacubitril valsartan in the treatment of chronic heart failure
Full
Qiang LU1, Yuelong NAN1, Xiaoping GUO1, *, Xiaoliang ZHANG2, Donghui SUN3, Wenzhong HAN1
Affiliations
  • 1.Department of Second Cardiovascular Diseases, Cangzhou Hospital of Integrated TCM WM Hebei, Cangzhou 061000, Hebei Province, China
  • 2.Department of Cardiology, Cangzhou Hospital of Integrated TCM WM Hebei, Orthopedic Hospital Area, Cangzhou 061000, Hebei Province, China
  • 3.Department of Interventional Medicine, Cangzhou Hospital of Integrated TCM WM Hebei, Cangzhou 061000, Hebei Province, China
Published: 2024-11-10 doi: 10.13683/j.wph.2024.11.007
Outline
收藏切换
Objective

To explore the efficacy of Linggui Zhugan decoction combined with sacubitril valsartan in patients with chronic heart failure (CHF).

Methods

A total of 124 patients with CHF admitted to our hospital from January 2022 to May 2023 were randomly divided into the control group (n=62, treated with sacubitril valsartan) and the observation group (n=62, Linggu Zhugan decoction+sacubitril valsartan). The clinical efficacy, echocardiographic parameters, serological parameters, vascular endothelial function and adverse reactions were compared between the two groups.

Results

The total effective rate of observation group was higher than that of control group (98.39% vs 80.65%, P<0.05). After treatment, left ventricular end-diastolic diameter decreased and left ventricular ejection fraction increased in both groups, and the improvement in the observation group was better than that in the control group (P<0.05). After treatment, the levels of interleukin-6, cyclophilin A, tumor necrosis factor-α and N-terminal brain natriuretic peptide precursor in both groups were decreased compared with those before treatment, and the improvement in the observation group was better than that in the control group (P<0.05). After treatment, nitric oxide was increased and endothelin-1 was decreased in both groups, and the improvement in the observation group was better than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (3.23% vs 16.13%, P<0.05).

Conclusion

Linggui Zhugan decoction combined with sacubitril valsartan can effectively improve the clinical efficacy of CHF patients, improve echocardiographic parameters, serological indexes and vascular endothelial function, and has better security.

Linggui Zhugan decoction  /  sacubitril valsartan  /  chronic heart failure
陆强, 南岳龙, 郭晓平, 张晓亮, 孙东辉, 韩文忠. 苓桂术甘汤联合沙库巴曲缬沙坦治疗慢性心力衰竭的临床观察. 世界临床药物, 2024 , 45 (11) : 1155 -1160 . DOI: 10.13683/j.wph.2024.11.007
Qiang LU, Yuelong NAN, Xiaoping GUO, Xiaoliang ZHANG, Donghui SUN, Wenzhong HAN. Clinical observation of Linggui Zhugan decoction combined with sacubitril valsartan in the treatment of chronic heart failure[J]. World Clinical Drug, 2024 , 45 (11) : 1155 -1160 . DOI: 10.13683/j.wph.2024.11.007
Year 2024 volume 45 Issue 11
12
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.11.007
  • Receive Date:2024-04-28
  • Online Date:2026-11-17
  • Published:2024-11-10
Article Data
Affiliations
History
  • Received:2024-04-28
Funding
Affiliations
    1.Department of Second Cardiovascular Diseases, Cangzhou Hospital of Integrated TCM WM Hebei, Cangzhou 061000, Hebei Province, China
    2.Department of Cardiology, Cangzhou Hospital of Integrated TCM WM Hebei, Orthopedic Hospital Area, Cangzhou 061000, Hebei Province, China
    3.Department of Interventional Medicine, Cangzhou Hospital of Integrated TCM WM Hebei, Cangzhou 061000, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.11.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT